Jim Cramer is Confident “Someone Will Want Some of Kenvue”

Kenvue Inc. (NYSE:KVUE) is one of the stocks on Jim Cramer’s radar. During the episode, Cramer discussed the company’s recent management change. He remarked:

“Consider Kenvue. Two years ago, this company was spun off by Johnson & Johnson, which just wanted to unload its fantastic consumer business… The company picked this fellow, Thibaut Mongon, and he’s the leader of, he was the leader of J&J’s Consumer Health division… We learned today that he was sacked after activist pressure, and Kirk Perry, a current director, was named interim CEO. Kenvue also announced a strategic review… That’s what we’re hoping will happen at Kraft Heinz.

Is this shocking? Was it amazing that Kenvue already got rid of the CEO in two years? Well, yes, if you saw the numbers. Kenvue reported minus 4% organic growth, and Wall Street was expecting plus 2 to 4%. But I bring this up because more deals are coming in that space… I’m extremely confident that someone will want some of Kenvue, if not all of Kenvue, because those brands grow slowly, but if you put a bunch of them together, you might have something that Wall Street gets very excited about.”

Jim Cramer is Confident "Someone Will Want Some of Kenvue"

A pharmacist at a local store, stocking shelves with products from the consumer health company.

Kenvue Inc. (NYSE:KVUE) develops and markets consumer health products across self-care, skin health, and essential health categories.

While we acknowledge the risk and potential of KVUE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KVUE and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.